Share Email Print

Proceedings Paper

Pigmentation in NIR laser tissue damage
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Damage from femtosecond mode-locked laser exposure (total exposure times longer than 20 microseconds) is predicted to be mediated by the same thermal mechanism found for continuous wave (CW) laser exposure. Experimentally, this trend holds true when comparing minimum visible lesions (MVL) from 0.25 s mode-locked and CW near-IR exposures in vivo. To further test this hypothesis in an in vitro setting we compared threshold values for cell death at various times post-exposure for mode-locked and CW 810-nm laser exposures. Using an artificially pigmented RPE cell culture system we show that damaging absorption of NIR laser light is directly related to the presence of melanin pigment granules, and that the damage thresholds for mode-locked and CW laser exposures are essentially the same for the pigmented cells. We additionally conclude that the artificially pigmented RPE cell cultures are a reasonable model system for the study of thermal and photomechanical forms of ocular laser tissue damage.

Paper Details

Date Published: 20 June 2003
PDF: 7 pages
Proc. SPIE 4953, Laser and Noncoherent Light Ocular Effects: Epidemiology, Prevention, and Treatment III, (20 June 2003); doi: 10.1117/12.476898
Show Author Affiliations
Michael L. Denton, Northrop Grumman IT (United States)
Debbie M. Eikum, Northrop Grumman IT (United States)
Gary D. Noojin, Northrop Grumman IT (United States)
David J. Stolarski, Northrop Grumman IT (United States)
Robert J. Thomas, Air Force Research Lab. (United States)
Randolph D. Glickman, Univ. of Texas Health Science Ctr. at San Antonio (United States)
Benjamin A. Rockwell, Air Force Research Lab. (United States)

Published in SPIE Proceedings Vol. 4953:
Laser and Noncoherent Light Ocular Effects: Epidemiology, Prevention, and Treatment III
Bruce E. Stuck; Michael Belkin, Editor(s)

© SPIE. Terms of Use
Back to Top